Project Grant R01AA031489
Award Date
6/1/25
Completion Date
2/28/30
Dollars Obligated
$688K
Federal Agency
National Institute on Alcohol Abuse and Alcoholism
Awardee
Yale Univ (FL6GV84CKN57)
Federal Grant Program
93.273
Assistance Type
Project Grant
Place of Performance
Connecticut, USA
Similar Awards
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $438,375 Project Grant under the Alcohol Research Programs (CFDA 93.273) to Cedars-Sinai Medical Center to establish a human liver-on-a-chip model for studying alcohol-associated liver disease (ALD). The 2-year project, starting September 2023, aims to investigate the roles of liver sinusoidal endothelial cells and acetaldehyde metabolism in regulating ethanol-induced liver damage as well as the contribution of fibrotic...
The federal Project Grant award R01AA031226, totaling $523,477.00, was provided by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) federal grant program. The award supports a research project focused on studying alcohol-associated liver disease (ALD) and its interaction with the rs738409 genetic variant in the PNPLA3 gene, utilizing a human induced pluripotent stem cell (hiPSC)-derived multicellular liver culture model. The key...
This Project Grant award, totaling $179,154, was provided by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) federal grant program. The award's objective is to elucidate novel mechanisms of alcohol-induced fibrotic gene reprogramming in the liver and identify specific factors amplifying hepatic stellate cell activation in alcohol-related liver disease. The awardee, the University of Colorado-Denver, will conduct research to...
This Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273), provides $380,863 to the University of Southern California (USC) to study the role of hepatic stellate cells (HSCs) in alcohol-associated hepatitis (AH). The key products and services to be delivered under this award include: Investigating the cross-regulation between the genes CYP1B1, PRRX1, and NR4A2 in the development of a novel subpopulation of...
This federal Project Grant award of $442,898, funded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273), aims to define the contributions of macrophage migration inhibitory factor (MIF) and its receptor CD74 in alcohol-associated liver disease (ALD). The research plan includes three specific aims: 1) characterizing the role of CD74 expression in hepatocytes and myeloid cells during and after ethanol feeding in mice, 2) resolving...
This $1,547,718 federal Project Grant award, funded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) program, supports research to investigate the role of H3K4 demethylases in alcohol-associated liver disease (ALD) development and resolution. The principal investigators from the University of Kansas Medical Center Research Institute, Inc. (KUMCRI) will use single-cell sequencing and co-culture experiments to determine how...
This federal Project Grant award of $220,656 from the National Institute on Alcohol Abuse and Alcoholism (CFDA 93.273 - Alcohol Research Programs) aims to study the role of non-isgylated HIV proteins in promoting liver fibrosis in people living with HIV, particularly those who also have alcohol use disorders. The key objectives are to: Investigate how ethanol metabolism suppresses the isgylation (modification by interferon-stimulated gene 15 proteins) of HIV proteins in hepatocytes, leading to...
This Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) will support research to investigate the effects of alcohol consumption on RNA modifications and their contribution to the development and progression of alcohol-associated liver disease (ALD). The $374,598 award will fund a study that will map the chemical modifications on different types of RNAs isolated from the livers of mice treated with alcohol, and...
This $119,600 Project Grant award, titled "LYSOSOME AND INTEGRATED STRESS RESPONSE IN AGING AND ALCOHOL-ASSOCIATED LIVER DISEASE", is funded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273). The award supports research aimed at identifying and understanding the mechanisms by which aging and alcohol consumption cooperatively contribute to the development of alcohol-associated liver disease (ALD). The research,...
This $151,869 federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) funding opportunity, will support research to investigate the relationship between chronic alcohol consumption, metabolic dysfunction, and the progression of Alzheimer's disease (AD). The key objectives of this 2-year project are to: 1) assess the influence of chronic ethanol exposure on metabolic function and tau pathology in the...